Teradyne price target raised to $105 from $90 at Cantor Fitzgerald

Cantor Fitzgerald analyst C.J. Muse raised the firm’s price target on Teradyne (TER) to $105 from $90 and keeps an Overweight rating on the shares. Cantor’s most recent industry checks point to modestly better Wafer Fab Equipment in calendar 2025, led by domestic China coupled with improving visibility to CY26 being another growth year, the analyst tells investors in a research note. The firm sees consensus estimates generally moving higher for the group, immune from tariff-related pull-in concerns, and China regulatory fears overblown.